• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经导管主动脉瓣置换术后再入院死亡率:教学医院地位与再入院原因的联合效应

Readmission Mortality After TAVR: The Combined Effect of Teaching Hospital Status and Cause of Readmission.

作者信息

Diaz-Castrillon Carlos E, Kliner Dustin, Serna-Gallegos Derek, Toma Catalin, Smith Aj Conrad, Gada Hemal, Makani Amber, Hasan Irsa, Ogami Takuya, Wang Yisi, Sultan Ibrahim

机构信息

Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Division of Cardiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

出版信息

CJC Open. 2025 Jan 27;7(4):481-488. doi: 10.1016/j.cjco.2024.12.014. eCollection 2025 Apr.

DOI:10.1016/j.cjco.2024.12.014
PMID:40433130
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12105757/
Abstract

BACKGROUND

Variability in transcatheter aortic valve replacement (TAVR) readmission rates highlights the importance of assessing post-discharge outcomes. Understanding how teaching hospital status and causes of readmission influence mortality could optimise post-TAVR care.

METHODS

Using the National Readmissions Database, we identified 155,298 TAVR admissions from 2012 to 2020. We evaluated the interaction effect between teaching status and cause of readmission on readmission-related mortality through adjusted mixed-effects models.

RESULTS

Overall, 18.9% of patients (n = 29,479) had a nonelective readmission within 90 days, with no significant difference between teaching and nonteaching hospitals (19.3% vs 18.9%; > 0.05). Cardiac-related readmissions accounted for 42.7% of cases, while noncardiac readmissions made up 57.3%, with no differences observed in their distribution between teaching and nonteaching hospitals. The unadjusted 90-day readmission mortality rate was 3.8%, without significant differences between teaching and nonteaching hospitals (3.8% vs 4.1%;  = 0.38). A downward trend in nonelective readmission and readmission-related mortality rates was observed, regardless of teaching status. An interaction effect between teaching status and the cause of readmission was identified: Noncardiac readmissions to teaching hospitals were associated with increased odds of death (odds ratio [OR] 1.82, 95% confidence interval [CI] 1.59-2.07; < 0.001) compared with nonteaching hospitals, whereas cardiac readmissions to teaching hospitals were associated with decreased odds of in-hospital mortality (OR 0.55, 95% CI 0.48-0.62; < 0.001).

CONCLUSION

Our findings indicate a differential association between teaching hospital status and 90-day readmission mortality, contingent on the cause of readmission. Further research, including the use of metrics such as failure to rescue, is needed to better understand the relationship between patient-level variables and teaching hospital status.

摘要

背景

经导管主动脉瓣置换术(TAVR)再入院率的差异凸显了评估出院后结局的重要性。了解教学医院状况和再入院原因如何影响死亡率有助于优化TAVR术后护理。

方法

利用国家再入院数据库,我们确定了2012年至2020年期间155,298例TAVR入院病例。我们通过调整后的混合效应模型评估了教学状况和再入院原因对再入院相关死亡率的交互作用。

结果

总体而言,18.9%的患者(n = 29,479)在90天内进行了非选择性再入院,教学医院和非教学医院之间无显著差异(19.3%对18.9%;P>0.05)。心脏相关再入院占病例的42.7%,而非心脏再入院占57.3%,教学医院和非教学医院之间在其分布上未观察到差异。未经调整的90天再入院死亡率为3.8%,教学医院和非教学医院之间无显著差异(3.8%对4.1%;P = 0.38)。无论教学状况如何,均观察到非选择性再入院率和再入院相关死亡率呈下降趋势。确定了教学状况和再入院原因之间的交互作用:与非教学医院相比,教学医院的非心脏再入院与死亡几率增加相关(优势比[OR]1.82,95%置信区间[CI]1.59 - 2.07;P<0.001),而教学医院的心脏再入院与住院死亡率降低相关(OR 0.55,95%CI 0.48 - 0.62;P<0.001)。

结论

我们的研究结果表明,教学医院状况与90天再入院死亡率之间存在差异关联,这取决于再入院原因。需要进一步研究,包括使用诸如未能挽救等指标,以更好地理解患者层面变量与教学医院状况之间的关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4dd/12105757/cc352be3d9fc/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4dd/12105757/1537f0864350/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4dd/12105757/a5a9f671e8ff/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4dd/12105757/7f73f336fe58/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4dd/12105757/cc352be3d9fc/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4dd/12105757/1537f0864350/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4dd/12105757/a5a9f671e8ff/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4dd/12105757/7f73f336fe58/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4dd/12105757/cc352be3d9fc/gr3.jpg

相似文献

1
Readmission Mortality After TAVR: The Combined Effect of Teaching Hospital Status and Cause of Readmission.经导管主动脉瓣置换术后再入院死亡率:教学医院地位与再入院原因的联合效应
CJC Open. 2025 Jan 27;7(4):481-488. doi: 10.1016/j.cjco.2024.12.014. eCollection 2025 Apr.
2
Outcomes of transcatheter aortic valve replacement at teaching versus nonteaching hospitals.教学医院与非教学医院经导管主动脉瓣置换术的疗效
J Card Surg. 2022 Nov;37(11):3550-3555. doi: 10.1111/jocs.16833. Epub 2022 Sep 8.
3
Incidence, Causes, and Predictors of Early (≤30 Days) and Late Unplanned Hospital Readmissions After Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术后早期(≤30 天)和晚期(>30 天)计划外再入院的发生率、原因和预测因素。
JACC Cardiovasc Interv. 2015 Nov;8(13):1748-57. doi: 10.1016/j.jcin.2015.07.022.
4
Association Between Hospital Volume and 30-Day Readmissions Following Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术后 30 天再入院与医院容量的相关性。
JAMA Cardiol. 2017 Jul 1;2(7):732-741. doi: 10.1001/jamacardio.2017.1630.
5
Hospital teaching status and trascatheter aortic valve replacement outcomes in the United States: Analysis of the national inpatient sample.美国医院教学状况与经导管主动脉瓣置换术的结果:全国住院患者样本分析
Catheter Cardiovasc Interv. 2017 Dec 1;90(7):1200-1205. doi: 10.1002/ccd.27236. Epub 2017 Aug 10.
6
Trends, Predictors, and Outcomes of 30-Day Readmission With Heart Failure After Transcatheter Aortic Valve Replacement: Insights From the US Nationwide Readmission Database.经导管主动脉瓣置换术后 30 天心力衰竭再入院的趋势、预测因素和结局:来自美国全国再入院数据库的见解。
J Am Heart Assoc. 2022 Aug 16;11(16):e024890. doi: 10.1161/JAHA.121.024890. Epub 2022 Aug 5.
7
Hospital Variation in 30-Day Readmissions Following Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术后 30 天内再入院的医院差异。
J Am Heart Assoc. 2021 May 18;10(10):e021350. doi: 10.1161/JAHA.120.021350. Epub 2021 May 3.
8
Early readmissions after transcatheter and surgical aortic valve replacement.经导管和外科主动脉瓣置换术后的早期再入院情况。
Catheter Cardiovasc Interv. 2017 Oct 1;90(4):662-670. doi: 10.1002/ccd.26945. Epub 2017 Mar 2.
9
Sex differences in mortality and 90-day readmission rates after transcatheter aortic valve replacement: a nationwide analysis from the USA.经导管主动脉瓣置换术后死亡率和 90 天再入院率的性别差异:来自美国的全国性分析。
Eur Heart J Qual Care Clin Outcomes. 2022 Mar 2;8(2):135-142. doi: 10.1093/ehjqcco/qcab012.
10
Long term mortality and readmissions after transcatheter aortic valve replacement.经导管主动脉瓣置换术后的长期死亡率和再入院情况。
Cardiovasc Diagn Ther. 2021 Aug;11(4):1002-1012. doi: 10.21037/cdt-20-916.

本文引用的文献

1
A Readmission Risk Score for Transcatheter Aortic Valve Replacement: An Analysis of 200,000 Patients.经导管主动脉瓣置换术的再入院风险评分:20 万名患者的分析。
Cardiovasc Revasc Med. 2023 Aug;53:8-12. doi: 10.1016/j.carrev.2023.02.025. Epub 2023 Mar 1.
2
Outcomes of transcatheter aortic valve replacement at teaching versus nonteaching hospitals.教学医院与非教学医院经导管主动脉瓣置换术的疗效
J Card Surg. 2022 Nov;37(11):3550-3555. doi: 10.1111/jocs.16833. Epub 2022 Sep 8.
3
Trends, Predictors, and Outcomes of 30-Day Readmission With Heart Failure After Transcatheter Aortic Valve Replacement: Insights From the US Nationwide Readmission Database.
经导管主动脉瓣置换术后 30 天心力衰竭再入院的趋势、预测因素和结局:来自美国全国再入院数据库的见解。
J Am Heart Assoc. 2022 Aug 16;11(16):e024890. doi: 10.1161/JAHA.121.024890. Epub 2022 Aug 5.
4
Unplanned Hospital Readmissions After Transcatheter Aortic Valve Replacement in the Era of New-Generation Devices.新一代器械时代经导管主动脉瓣置换术后非计划性医院再入院。
J Invasive Cardiol. 2022 Apr;34(4):E299-E309. doi: 10.25270/jic/21.00192. Epub 2022 Mar 25.
5
Long term mortality and readmissions after transcatheter aortic valve replacement.经导管主动脉瓣置换术后的长期死亡率和再入院情况。
Cardiovasc Diagn Ther. 2021 Aug;11(4):1002-1012. doi: 10.21037/cdt-20-916.
6
Frailty Predicts Adverse Outcomes in Older Patients Undergoing Transcatheter Aortic Valve Replacement (TAVR): From the National Inpatient Sample.衰弱预测老年行经导管主动脉瓣置换术(TAVR)患者的不良结局:来自全国住院患者样本。
Cardiovasc Revasc Med. 2022 Jan;34:56-60. doi: 10.1016/j.carrev.2021.02.004. Epub 2021 Feb 6.
7
STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术的STS-ACC TVT注册研究
J Am Coll Cardiol. 2020 Nov 24;76(21):2492-2516. doi: 10.1016/j.jacc.2020.09.595.
8
Impact of Frailty on Mortality, Readmissions, and Resource Utilization After TAVI.经导管主动脉瓣置换术(TAVI)后衰弱对死亡率、再入院率和资源利用的影响。
Am J Cardiol. 2020 Jul 15;127:120-127. doi: 10.1016/j.amjcard.2020.03.047. Epub 2020 Apr 24.
9
The Effect and Relationship of Frailty Indices on Survival After Transcatheter Aortic Valve Replacement.衰弱指数对经导管主动脉瓣置换术后生存的影响及关系。
JACC Cardiovasc Interv. 2020 Jan 27;13(2):219-231. doi: 10.1016/j.jcin.2019.08.015.
10
Utility of 90-Day Mortality vs 30-Day Mortality as a Quality Metric for Transcatheter and Surgical Aortic Valve Replacement Outcomes.90 天死亡率与 30 天死亡率作为经导管主动脉瓣置换术和外科主动脉瓣置换术结果的质量指标的效用。
JAMA Cardiol. 2020 Feb 1;5(2):156-165. doi: 10.1001/jamacardio.2019.4657.